Correlation Between Day One and Ginkgo Bioworks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Day One and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Ginkgo Bioworks.

Diversification Opportunities for Day One and Ginkgo Bioworks

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Day and Ginkgo is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Day One i.e., Day One and Ginkgo Bioworks go up and down completely randomly.

Pair Corralation between Day One and Ginkgo Bioworks

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.58 times more return on investment than Ginkgo Bioworks. However, Day One Biopharmaceuticals is 1.72 times less risky than Ginkgo Bioworks. It trades about -0.02 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.03 per unit of risk. If you would invest  2,341  in Day One Biopharmaceuticals on October 7, 2024 and sell it today you would lose (1,082) from holding Day One Biopharmaceuticals or give up 46.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Ginkgo Bioworks Holdings

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Ginkgo Bioworks Holdings 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ginkgo Bioworks Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ginkgo Bioworks sustained solid returns over the last few months and may actually be approaching a breakup point.

Day One and Ginkgo Bioworks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Ginkgo Bioworks

The main advantage of trading using opposite Day One and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.
The idea behind Day One Biopharmaceuticals and Ginkgo Bioworks Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance